ALSO NOTED: Appeals court votes for FDA approval shield; Suicides rose as depression treatment fell;

> A federal appeals court backed the drug industry's arguments that it should be insulated from lawsuits over FDA-approved products, ruling 2-1 that antidepressant makers GlaxoSmithKline and Pfizer could not be held liable for the suicides of two patients using SSRIs. Report

> A new study shows rising suicide rates among children and teens in Canada, two years after drug regulators there warned of the safety risks of antidepressant use in children; the climbing suicide rate coincided with a 10 percent drop in the rate of doctor visits for depression treatment among children. Report

> Galderma Pharma has wrapped up its $420 million tender offer for fellow dermatology drug company CollaGenex Pharmaceuticals. Report

> Louisiana's new attorney general withdrew a multimillion-dollar antitrust lawsuit filed against Amgen by his predecessor. Report

> The healthcare and IT company McKesson has agreed to pay $190 million for McQueary Brothers Drug Co., a pharma and beauty products distributor based in Springfield, Mo. Report

> Novartis' plans to erect three wind turbines on its Grimsby, England, campus have drawn fire from environmentalists worried that the huge windmills might disturb birds. Report

> India's Dabur Pharma has agreed to supply Thailand with a copycat form of Sanofi-Aventis' Taxotere, which the Thai government is importing under a patent-busting compulsory license. Report

> Estrogen-only hormone replacement therapy has been linked to a benign breast-lump disease that's often a precursor to cancer. Report

> There's a shakeup under way at Inotek. The Beverly, MA-based developer says it is closing several international sites and a pilot manufacturing facility in Israel as it focuses all of its efforts on its two main programs and two preclinical programs. Report

> Endo Pharmaceuticals says a close reading of a non-approvable letter from the FDA for Frova prompted officials to pull their request to gain approval for the short-term relief of menstrual migraine. Report

> Scientists at Memorial Sloan-Kettering Cancer Center in New York City have identified the molecular process by which breast cancer cells spread to other tissue during metastasis. Report

And Finally... Russia has improbably emerged as a world leader in new cancer vaccines. The country's regulatory body approved the use of Antigenics' new kidney cancer vaccine, Oncophage--a world first. Report

Suggested Articles

The efficacy between Keytruda and FerGene's nadofaragene firadenovec look comparable in their studies, though Merck has at least one upper hand.

Thursday, the FDA approved the first three generic versions of Gilenya, but they may not hit the market anytime soon due to ongoing litigation.

Gilead is hoping to score a patent extension on TAF meds, but patient advocates say that would reward conduct that harmed patients.